FI113279B - Menetelmiä HMG-CoA-reduktaasi-inhibiittorien valmistamiseksi - Google Patents

Menetelmiä HMG-CoA-reduktaasi-inhibiittorien valmistamiseksi Download PDF

Info

Publication number
FI113279B
FI113279B FI944926A FI944926A FI113279B FI 113279 B FI113279 B FI 113279B FI 944926 A FI944926 A FI 944926A FI 944926 A FI944926 A FI 944926A FI 113279 B FI113279 B FI 113279B
Authority
FI
Finland
Prior art keywords
formula
compound
atcc
microorganism
process according
Prior art date
Application number
FI944926A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI944926A0 (fi
FI944926A (fi
Inventor
Brian L Davis
Paul M Cino
Laszlo Szarka
Original Assignee
Squibb Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb Bristol Myers Co filed Critical Squibb Bristol Myers Co
Publication of FI944926A0 publication Critical patent/FI944926A0/fi
Publication of FI944926A publication Critical patent/FI944926A/fi
Application granted granted Critical
Publication of FI113279B publication Critical patent/FI113279B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/872—Nocardia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI944926A 1993-10-22 1994-10-20 Menetelmiä HMG-CoA-reduktaasi-inhibiittorien valmistamiseksi FI113279B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14131693 1993-10-22
US08/141,316 US6043064A (en) 1993-10-22 1993-10-22 Enzymatic hydroxylation process for the preparation of HMG-CoA reductase inhibitors and intermediates thereof

Publications (3)

Publication Number Publication Date
FI944926A0 FI944926A0 (fi) 1994-10-20
FI944926A FI944926A (fi) 1995-04-23
FI113279B true FI113279B (fi) 2004-03-31

Family

ID=22495167

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944926A FI113279B (fi) 1993-10-22 1994-10-20 Menetelmiä HMG-CoA-reduktaasi-inhibiittorien valmistamiseksi

Country Status (20)

Country Link
US (1) US6043064A (zh)
EP (1) EP0649907B1 (zh)
JP (1) JP3683606B2 (zh)
KR (1) KR100342627B1 (zh)
CN (1) CN1085250C (zh)
AT (1) ATE196166T1 (zh)
AU (1) AU679113B2 (zh)
CA (1) CA2134025A1 (zh)
CY (1) CY2216B1 (zh)
DE (1) DE69425801T2 (zh)
DK (1) DK0649907T3 (zh)
ES (1) ES2150459T3 (zh)
FI (1) FI113279B (zh)
GR (1) GR3034835T3 (zh)
HK (1) HK1014740A1 (zh)
HU (1) HU217104B (zh)
IL (1) IL111084A (zh)
PT (1) PT649907E (zh)
SG (1) SG47504A1 (zh)
TW (1) TW438888B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100433888B1 (ko) 1997-08-07 2004-06-04 교와 핫꼬 고교 가부시끼가이샤 ＨＭＧ-ＣｏＡ 환원효소 저해제의 제조법
WO1999010499A1 (en) * 1997-08-22 1999-03-04 Dsm N.V. Statin production by fermentation
SI9800144A (sl) * 1998-05-21 1999-12-31 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Nov biotehnološki postopek pridobivanja 3-hidroksi-ML-236B derivatov poznanih kot M-4 in M-4'
KR100633867B1 (ko) 1999-01-20 2006-10-16 교와 핫꼬 고교 가부시끼가이샤 히드록시메틸글루타릴 코에이 환원효소 저해제의 제조방법
HUP0105145A3 (en) * 1999-01-29 2006-02-28 Kyowa Hakko Kogyo Kk Process for producing hmg-coa reductase inhibitor
HUP9902352A1 (hu) * 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
JP2003093045A (ja) * 2001-09-26 2003-04-02 Godo Shusei Co Ltd 有用変換微生物
MXNL04000022A (es) * 2001-09-27 2004-11-26 Biocon Ltd Proceso para la produccion de pravastatina de sodio usando flavidovirenos estreptomicios dsm 14455.
EP1452602A1 (en) * 2003-02-25 2004-09-01 Antibiotic Co., Method for production of pravastatin by fermentation
TWI252253B (en) * 2004-01-09 2006-04-01 Chinese Petroleum Corp A novel Pseudonocardia sp RMRC PAH4 and a process for bioconverting compactin into pravastatin using the same
CN101351551A (zh) * 2005-11-29 2009-01-21 协和发酵工业株式会社 新型蛋白质和编码该蛋白质的dna
WO2007137816A1 (en) * 2006-05-30 2007-12-06 Dsm Ip Assets B.V. Process for the preparation of epoxide intermediates for pharmaceutical compounds such as statins
EP1953233A1 (en) * 2007-02-02 2008-08-06 LEK Pharmaceuticals d.d. Fermentation process for preparing pravastatin
WO2018226893A2 (en) 2017-06-06 2018-12-13 Zymergen Inc. A high-throughput (htp) genomic engineering platform for improving saccharopolyspora spinosa

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (zh) * 1974-06-07 1981-03-18
US4206206A (en) * 1977-03-24 1980-06-03 Kowa Company, Ltd. Antibiotics of the KA-6606 series and pharmaceutical compositions thereof
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
US4450171A (en) * 1980-08-05 1984-05-22 Merck & Co., Inc. Antihypercholesterolemic compounds
DE3262386D1 (en) * 1981-06-06 1985-03-28 Pfizer Ltd Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
JPS5889191A (ja) * 1981-11-20 1983-05-27 Sankyo Co Ltd ３−ヒドロキシ−ｍｌ−２３６ｂ誘導体の製造法
JPS60176595A (ja) * 1984-02-21 1985-09-10 Akira Endo 生理活性物質ｍｌ−２３６ａ及びモナコリンｊの製造法
PT85109A (en) * 1986-06-23 1987-07-01 Merck & Co Inc Process for the preparation of hydroxy-tetrahydropyranone derivatives or corresponding ring opened dihydroxy acids which are hmg-coa reductase inhibitors
US4857547A (en) * 1988-01-07 1989-08-15 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
EP0337548A3 (en) * 1988-04-15 1991-08-14 Merck & Co. Inc. HMG-COA reductase inhibitors produced by nocardia SP. (MA6455)(ATCC 53695)
EP0381478A1 (en) * 1989-02-01 1990-08-08 Merck & Co. Inc. Process for the preparation of 6-alpha-hydroxymethyl lovastatin derivatives
EP0408806A1 (en) * 1989-07-19 1991-01-23 Merck & Co. Inc. Antihypercholesterolemic agents
MY106564A (en) * 1990-07-06 1995-06-30 Squibb & Sons Inc Sulfur-substituted mevinic acid derivatives.
CA2053000C (en) * 1990-10-15 1995-08-29 Michael J. Conder Biosynthetic production of 6(r)-[2-(8(s)-hydroxy-2(s), 6(r)-dimethyl-1,2,6,7,8,8a(r)-hexahydronaphthyl)-ethyl]-4 (r)-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-one triol acid by enzymatic hydrolysis of lovastatin acid using an enzyme derived from__lonostachys compactiuscula
IL108432A (en) * 1993-01-29 1997-09-30 Sankyo Co DERIVATIVES OF 3, 5-DIHYDROXY-7- £1, 2, 6, 7, 8, 8a-HEXAHYDRO-2- METHYL-8- (SUBSTITUTED ALKANOYLOXY)-1-NAPHTHYL| HEPTANOIC ACID AND THEIR LACTONES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
ES2150459T3 (es) 2000-12-01
JPH07184670A (ja) 1995-07-25
DK0649907T3 (da) 2000-10-09
DE69425801D1 (de) 2000-10-12
EP0649907A1 (en) 1995-04-26
AU679113B2 (en) 1997-06-19
CN1106067A (zh) 1995-08-02
EP0649907B1 (en) 2000-09-06
HU217104B (hu) 1999-11-29
CN1085250C (zh) 2002-05-22
KR950011616A (ko) 1995-05-15
IL111084A0 (en) 1994-11-28
DE69425801T2 (de) 2001-05-03
HK1014740A1 (en) 1999-09-30
TW438888B (en) 2001-06-07
HUT69959A (en) 1995-09-28
CA2134025A1 (en) 1995-04-23
IL111084A (en) 1998-01-04
GR3034835T3 (en) 2001-02-28
ATE196166T1 (de) 2000-09-15
CY2216B1 (en) 2003-04-18
US6043064A (en) 2000-03-28
FI944926A0 (fi) 1994-10-20
PT649907E (pt) 2000-12-29
JP3683606B2 (ja) 2005-08-17
AU7597294A (en) 1995-05-11
KR100342627B1 (ko) 2002-11-18
HU9403061D0 (en) 1994-12-28
SG47504A1 (en) 1998-04-17
FI944926A (fi) 1995-04-23

Similar Documents

Publication Publication Date Title
FI113279B (fi) Menetelmiä HMG-CoA-reduktaasi-inhibiittorien valmistamiseksi
KR100323572B1 (ko) Fo-1289 물질 및 그의 생산방법
JPH06233695A (ja) ケトン類の立体選択的還元
CA2053000C (en) Biosynthetic production of 6(r)-[2-(8(s)-hydroxy-2(s), 6(r)-dimethyl-1,2,6,7,8,8a(r)-hexahydronaphthyl)-ethyl]-4 (r)-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-one triol acid by enzymatic hydrolysis of lovastatin acid using an enzyme derived from__lonostachys compactiuscula
US5620876A (en) Enzymatic hydrolysis and esterification processes for the preparation of HMG-CoA reductase inhibitors and intermediates thereof
JPH0348673A (ja) ３―ケト、５―ヒドロキシシンバスタチンアナログの製造方法
CA2202016A1 (en) Process for the production of lipstatin and of tetrahydrolipstatin
EP0070649B1 (en) Ml-236b derivatives, a process for their preparation and pharmaceutical compositions containing them
US4997755A (en) HMG-CoA reductase inhibitors produced by Nocardia sp. (MA 6455)
CA2129416A1 (en) Fermentation process for preparation of antihypercholesteremic products
EP0151419A2 (en) Method of preparing D(-)-beta-hydroxyisobutyric acid by fermentation
US5106736A (en) Enzymatic process for enantiomer-specific perparation of mercapto alkanoic acid compounds
IE902338L (en) Resolution of pyrrolidone carboxylic acid esters
EP0381478A1 (en) Process for the preparation of 6-alpha-hydroxymethyl lovastatin derivatives
US4618583A (en) Method of preparing L-(+)-β-hydroxyisobutyric acid by fermentation
US4981794A (en) Method of preparing D(-)-β-hydroxyisobutyric acid by fermentation
US5814512A (en) Microorganism having all the identifying characteristics of absida ferm BP-4599 for producing purpurogallin derivatives
EP0337548A2 (en) HMG-COA reductase inhibitors produced by nocardia SP. (MA6455)(ATCC 53695)
EP0590083A1 (en) Novel cholesterol lowering compound
JP3103539B2 (ja) 微生物生体内変換による特定の化合物の製造方法
JP4263741B2 (ja) プラバスタチンナトリウムの生産に用いる微生物およびそれによるプラバスタチンナトリウムの製造方法
EP1026235A1 (en) Levodione reductase
KR20010039357A (ko) 효소적 비대칭 환원에 의한 광학활성 2차 알코올의 제조방법
CA2521276A1 (en) Fermentation process for the preparation of pravastatin
EP0598021A1 (en) Novel cholesterol lowering compound

Legal Events

Date Code Title Description
MA Patent expired